Advisors Asset Management, Inc. Eli Lilly & CO Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 40,932 shares of LLY stock, worth $30.8 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

40,932

Previous 47,854 14.46%

Holding current value

$30.8 Million

Previous $43.3 Million 16.3%

% of portfolio

0.69%

Previous 0.87%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $5.34 Million - $6.65 Million	-6,922 Reduced 14.46%	40,932 $36.3 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $7.98 Million - $10 Million	-11,009 Reduced 18.7%	47,854 $43.3 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $5.11 Million - $6.84 Million	-8,636 Reduced 12.79%	58,863 $45.8 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $3.95 Million - $4.65 Million	-7,515 Reduced 10.02%	67,499 $39.3 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.36 Million - $1.82 Million	-3,875 Reduced 4.91%	75,014 $35.2 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $254,405 - $298,787	819 Added 1.05%	78,889 $27.1 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $58,999 - $67,236	-199 Reduced 0.22%	89,156 $28.8 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $1.96 Million - $2.31 Million	-7,049 Reduced 7.31%	89,355 $29 Million
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $1.12 Million - $1.39 Million	-4,771 Reduced 4.72%	96,404 $27.6 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $206,862 - $256,716	920 Added 0.92%	101,175 $27.9 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $24,819 - $30,543	-112 Reduced 0.11%	100,255 $23.2 Million
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $1.24 Million - $1.6 Million	-6,872 Reduced 6.41%	100,367 $23 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $1.33 Million - $1.72 Million	8,077 Added 8.15%	107,239 $20 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $872,255 - $1.15 Million	6,686 Added 7.23%	99,162 $16.7 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $118,876 - $137,502	-813 Reduced 0.87%	92,476 $13.7 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $602,294 - $724,854	4,415 Added 4.97%	93,289 $15.3 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $644,060 - $797,163	5,410 Added 6.48%	88,874 $12.3 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $755,389 - $935,617	7,065 Added 9.25%	83,464 $12.6 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $1.31 Million - $1.42 Million	12,264 Added 19.12%	76,399 $8.54 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $4.38 Million - $5.11 Million	-39,508 Reduced 38.12%	64,135 $7.11 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $400,382 - $471,278	-3,597 Reduced 3.35%	103,643 $13.4 Million
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $1.35 Million - $1.51 Million	12,712 Added 13.45%	107,240 $12.4 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $39,581 - $49,469	-461 Reduced 0.49%	94,528 $10.1 Million
Q2 2018 Aug 22, 2018	BUY	$75.7 - $86.88 $4.26 Million - $4.89 Million	56,295 Added 145.49%	94,989 $8.11 Million
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $5.9 Million - $6.77 Million	-77,937 Reduced 66.82%	38,694 $8.11 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $592,789 - $699,748	-7,988 Reduced 6.41%	116,631 $8.99 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $547,359 - $587,105	-6,680 Reduced 5.09%	124,619 $10.5 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $10.1 Million - $11.2 Million	131,299	131,299 $11.2 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Eli Lilly & CO Transaction History